DROPSORDRY^™

Proprietary blend of botanicals from SOLGEN soybean isoflavones and Cucurbita pepo.

Contains high levels of genistin & genistein isoflavones, the phytoestrogen that favorably contributes in menopause urinary incontinence

Genistein therapy regressed the degenerative changes associated at OAB symptoms^*(2).

Proprietary clinical studies in European women^*(3-7)

73% reduction of urine leakages^*(4)

46% reduction of urge urinary incontinence episodes^*(3)

52% reduction of stress incontinence episodes (SUI)^*(4)

69% reduction in nocturia^*(5,6)

60% reduction in volume of nocturnal diuresis^*(5)

66% reduction in daily panty-liners^*(4)

GMP manufacturing (Tradichem Industrial Services)

2 x 500mg for the first 4 weeks.

1 x 500mg for the following 20 weeks.